Aditxt (NASDAQ:ADTX) Shares Up 8% – Should You Buy?

Shares of Aditxt, Inc. (NASDAQ:ADTX) rose 8% during mid-day trading on Monday . The stock traded as high as $0.7999 and last traded at $0.7030. Approximately 336,925 shares were traded during trading, a decline of 91% from the average daily volume of 3,791,170 shares. The stock had previously closed at $0.6510.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Aditxt Stock Performance

The firm’s 50 day moving average is $1.30 and its 200 day moving average is $48.15. The stock has a market cap of $513,190.00, a P/E ratio of 0.00 and a beta of 1.49.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.